Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading

Mervat Mahmoud Mostafa Eissa;

Abstract


Background: Bone loss in rheumatoid arthritis (RA) is caused by increased bone resorption, however, there is no increased bone formation. The Wnt pathway is important in the control of bone formation through regulation of osteoblast activity. Sclerostin


Other data

Title Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading
Other Titles دراسة عن مستوي السكليروستين بمرضى الروماتويد المصريين وعلاقته بكثافة العظام و نشاط المرض و الأشعة
Authors Mervat Mahmoud Mostafa Eissa
Keywords Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading
Issue Date 2013
Description 
Background: Bone loss in rheumatoid arthritis (RA) is caused by increased bone resorption, however, there is no increased bone formation. The Wnt pathway is important in the control of bone formation through regulation of osteoblast activity. Sclerostin

Attached Files

File SizeFormat
120869R9434.pdf221.78 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.